Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine for Early Stage Breast Cancer

NCT00415285 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasms

Interventions

DRUG: Docetaxel
DRUG: Capecitabine
DRUG: Docetaxel/Capecitabine

Sponsor

Georgia Center for Oncology Research & Education

Collaborators

[object Object]